The unsustainable trajectory of global healthcare and ways forward
At Copenhagen Economics’ Healthcare & Life Sciences service, we see a number of completely uncoordinated events in contemporary healthcare, which we do not believe are unrelated.
In fact, the events seem to be consequences of a growing global gap between healthcare systems’ ambition to curb rising costs through price-focused procurement models and pharmaceutical companies’ ambition to secure high prices anchored to the value that their medicines create for patients and society at large.
In conclusion, we find that the current trajectory is unsustainable.
In the articles below, we share our view on how companies and healthcare systems can take steps to change the trajectory away from a breakdown, towards a long-term sustainable path for all parties.
The published articles comprise:
- Is a showdown approaching within the healthcare sector? Why seemingly unrelated events are not and what it means for pharma and payers in Europe. Please download here.
- The way forward: Value-based healthcare in partnerships.
Please download here.
- Unfair pricing or unfit procurement? Avoiding disputes between payers and suppliers of pharmaceuticals.
Please download here.
- Expensive innovative treatments: How to increase patient access and avoid conditional reimbursement approvals.
Please download here.
- The fair bet in pharma pricing: An investor’s perspective.
Please download here.
- Stepping up your game: How pharmaceutical and device suppliers can use game theory to improve their strategy in public procurement processes.
Please download here.
